Data demonstrating that synthetic, chemically-modified 19-bp siRNAs, including PF 04523655 currently being studied by partners Pfizer and Quark in patients with diabetic macular edema (DME) and age-related macular degeneration (AMD), …
Ophthalmology This month, the Journal of the American Academy of Ophthalmology (Academy) reports on a national study finds, the cataract surgery is likely in patients with age-related macular degeneration (AMD) in all phases of the …
Quarks partner, Pfizer Inc, currently is evaluating PF-4523655 (RTP801i-14) in two Phase 2 clinical studies in patients with diabetic macular edema(DME) and age-related macular degeneration(AMD). PF-4523655 is a synthetic, …
